BC Advantage Funds (VCC) Ltd.

BC Advantage Funds (VCC) Ltd.

February 16, 2012 19:02 ET

BC Advantage Funds Announces Robert W. Rieder as a New Director

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Feb. 16, 2012) - BC Advantage Funds (VCC) Ltd. announced today that Robert W. (Bob) Rieder has joined its Board of Directors. Mr. Rieder is Chairman of the Board of Cardiome Pharma Corp. (NASDAQ:CRME)(TSX:COM), and previously served as Cardiome's Chief Executive Officer from 1998 to 2009.

Frank Holler, Chairman and CEO of Advantage, said, "It is a pleasure to welcome an individual of Bob's stature and experience to the Advantage board of directors. Having spent his entire career working in leadership positions with prominent venture capital and technology firms, I know Bob will be a strong contributor to our board."

Mr. Rieder has extensive experience in venture capital and the operational management of life science and technology companies. Prior to joining Cardiome, he was Vice-President at MDS Ventures Pacific Inc., the Vancouver-based affiliate of MDS Capital Corp., and has served as a director for nine public and private technology companies. Mr. Rieder has also acted as Chief Operating Officer for DBA Telecom Inc., and CEO for Synapse Technologies Inc. He holds a MBA degree from the University of Western Ontario.

About Advantage

BC Advantage Funds (VCC) Ltd. is a venture capital corporation, formed under the Small Business Venture Capital Act (British Columbia), to invest in emerging technology companies in the Province. For more information about Advantage, please visit our website at www.bcadvantagefunds.com.

Contact Information